Stockreport

Delphia Therapeutics Launches to Pioneer a New Field of Cancer Medicines: Activation Lethality [Yahoo! Finance]

IDEAYA Biosciences, Inc.  (IDYA) 
Last ideaya biosciences, inc. earnings: 3/24 06:00 am Check Earnings Report
PDF Delphia is leveraging its activation lethality platform to develop highly differentiated, first-in-class targeted cancer medicines with the potential for significant an [Read more]